Red Door Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
EHC
SRIM
MG
OAM
SAM
Red Door Wealth Management's NVO Position: Q2 2026 in Review
Red Door Wealth Management reduced its Novo Nordisk (NVO) stake by 2.7% in Q2 2026, selling an estimated $17.5K and leaving 14,577 shares worth $699K. The position accounts for 0.06% of the portfolio, ranked #151.
Red Door Wealth Management first reported a position in NVO in Q1 2020 and has held it in 16 quarters since. The position peaked at $826K in Q4 2024. 654 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Red Door Wealth Management held 14,577 shares of Novo Nordisk worth $699K as of Q2 2026.
- Red Door Wealth Management sold 408 Novo Nordisk shares in Q2 2026, an estimated $17.5K.
- Novo Nordisk made up 0.06% of Red Door Wealth Management's portfolio in Q2 2026, its #151 holding.
- Red Door Wealth Management first reported a position in Novo Nordisk in Q1 2020 and has held it in 16 quarters since.
- Red Door Wealth Management's Novo Nordisk position peaked at $826K in Q4 2024.
- 654 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Red Door Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.